2Flo Ventures appoints Dr. Charlotte Jones-Burton as Partner and Head of Life Science Product Development and Strategy.

2Flo Ventures appoints Dr. Charlotte Jones-Burton, a renowned life sciences executive with 20 years of experience, as Partner and Head of Life Science Product Development and Strategy. She previously led clinical development at Chinook Therapeutics, which was acquired by Novartis for $3.2bn. Prior to that, she held roles at Otsuka Pharmaceuticals and founded Women of Color in Pharma (WOCIP®).